NCT04711590

Brief Summary

Weaning ventilator support in critically ill patients is crucial. Both delayed extubation and unexpected early reintubation are harmful to the patients. Weaning parameters and spontaneous breathing trial are used to investigate the indication and predict the successful extubation. Hemodynamic stability and physical reserve are important indicators as well. Microcirculation parameters are known to be more sensitive to the change of hemodynamic status than macrocirculation parameters. We hypothesize that the change of sublingual microcirculation before and after spontaneous breathing trial is different between the the patients with successful extubation and the patients with failed extubation. Thus, this study measures sublingual microcirculation in patients receiving spontaneous breathing trial and record the extubation status (successful or failed). The microcirculation parameters before and after spontaneous breathing trial are compared between the the patients with successful extubation and the patients with failed extubation.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
59

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Dec 2019

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

December 5, 2019

Completed
1.1 years until next milestone

First Submitted

Initial submission to the registry

January 13, 2021

Completed
2 days until next milestone

First Posted

Study publicly available on registry

January 15, 2021

Completed
1.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 13, 2022

Completed
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

September 30, 2022

Completed
Last Updated

December 14, 2022

Status Verified

April 1, 2022

Enrollment Period

2.5 years

First QC Date

January 13, 2021

Last Update Submit

December 12, 2022

Conditions

Keywords

ventilatorweaningmicrocirculation

Outcome Measures

Primary Outcomes (2)

  • Initial total vessel density

    Total vessel density measured by Cytocam before and after spontaneous breathing trial

    0 hour

  • Change of total vessel density

    The difference between the total vessel density measure by Cytocam before and after spontaneous breathing trial

    baseline and 1 hour

Secondary Outcomes (2)

  • Initial perfused vessel density

    0 hour

  • Change of perfused vessel density

    baseline and 1 hour

Study Arms (2)

Successful extubation

The patients pass the spontaneous breathing trial and are successful extubated without reintubation within 72 hours. .

Other: Microcirculation examination

Failed extubation

The patients pass the spontaneous breathing trial and are successful extubated with reintubation within 72 hours. .

Other: Microcirculation examination

Interventions

Sublingual microcirculation images were recorded using an incident dark-field video microscope

Failed extubationSuccessful extubation

Eligibility Criteria

Age20 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Critically ill patients who are ready for weaning ventilator support and receive spontaneous breathing trial.

You may qualify if:

  • critically ill patients received ventilator longer than 12 hours
  • ready for spontaneous breathing trial
  • GCS coma score equal or higher than 8

You may not qualify if:

  • aged less than 20 years
  • patient with tracheostomy
  • patient and patients' relatives are non-native speakers

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

National Taiwan University Hospital

Taipei, 10002, Taiwan

Location

MeSH Terms

Conditions

Critical Illness

Condition Hierarchy (Ancestors)

Disease AttributesPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 13, 2021

First Posted

January 15, 2021

Study Start

December 5, 2019

Primary Completion

June 13, 2022

Study Completion

September 30, 2022

Last Updated

December 14, 2022

Record last verified: 2022-04

Locations